F4 FundFund
TeamPortfolioRaiseChampionsEssays
Sign in
Investment ThesisInvestment TeamF4 Research BriefSelected PortfolioRecent UpdatesSimilar Firms
Warm Fund

Pentland Ventures

pentland.vc · London, UK

“Pentland Ventures invests in exciting and uplifting brands that help people live healthier and more sustainable lives, drawing on Pentland Group's operating heritage in athletic, outdoor, and consumer brands (Speedo, Berghaus, Endura, Mitre) and its majority stake in JD Sports Fashion plc.”

$500K – $5M
Check Size
Leads & Follows
Lead Tendency
01Investment Thesis

Pentland Ventures invests in exciting and uplifting brands that help people live healthier and more sustainable lives, drawing on Pentland Group's operating heritage in athletic, outdoor, and consumer brands (Speedo, Berghaus, Endura, Mitre) and its majority stake in JD Sports Fashion plc.

Exclusion Criteria

No antithesis publicly stated. Portfolio composition suggests avoidance of pure enterprise software, B2B SaaS, and deep-tech infrastructure investments outside the consumer health and wellness remit.

02Investment Team
CR
Charlie Rubin
Partner
LG
Lucas Giacomelli
Principal
KM
Katie Martin
Investment Manager
OH
Omar Hattea
Investment Manager
03F4 Research Brief

Pentland Ventures Research

Investment Thesis

Pentland Ventures is the direct-investment vehicle of Pentland Group, the privately held Rubin family business that owns Speedo, Berghaus, Endura, and Mitre, is the global footwear licensee for Lacoste, and is the majority shareholder of JD Sports Fashion plc (3,400+ stores across 38 countries). The firm's public positioning is narrow and deliberate: "exciting and uplifting brands that help people live healthier and more sustainable lives." In practice its cap table skews toward consumer health, wellness, and better-for-you food brands, with a smaller number of sports-performance and consumer-health-diagnostics bets that plausibly draw on Pentland Group's operating heritage in athletic and outdoor brands (e.g., a Speedo-adjacent wearables company, GPS sports-performance tracking).

Stage Focus

Public evidence points to seed through growth-stage participation rather than a single fixed stage mandate. Confirmed rounds span a $3M seed (Sarelly), a $12M Series A (PlayerData), a $19M Series A (Sava), and a £20M growth round (Seat Unique). Third-party trackers (Tracxn, PitchBook, Caplight) describe the firm as most active at Seed through Series A, with occasional larger follow-on or co-investment participation.

Check Size

Third-party sources (Hopohopo) cite a typical range of roughly £500K–£5M per investment. This has not been independently confirmed from a primary Pentland source, so confidence on exact bounds is moderate.

Lead Tendency

Mixed. Pentland Ventures is credited as a lead investor in PlayerData's $12M Series A (alongside Darco Ventures and Bolt Ventures), but appears as a participant rather than lead in Sarelly's seed round, Sava's Series A, and Seat Unique's growth round. This is consistent with a family-office pattern of writing both anchor and follower checks depending on relationship and conviction.

Recent Activity

The firm has been active through 2025 and 2026: Sarelly (Mexican clean-beauty and accessories brand) closed a $3M seed round in July 2025 with Pentland Ventures backing; Sava Technologies (continuous glucose monitoring biosensor) closed a $19M Series A in July 2025 with Pentland investor Charlie Rubin quoted in coverage; PlayerData (GPS sports-performance wearables) raised a $12M Series A in May 2026 led by Pentland Ventures, Darco Ventures, and Bolt Ventures, with Kevin Durant's 35V as a strategic investor; and Seat Unique (premium ticketing and hospitality platform backed by England captain Harry Kane) raised £20M in June 2026. Tracxn counted three Pentland Ventures investments in 2026 through mid-year, consistent with an actively deploying posture.

Portfolio Highlights

Consumer health/wellness and food brands featured on Pentland's own site include Algae Cooking Club (algae-oil cooking products), Brami (men's underwear), Cadence (modular travel organization system), Catalina Crunch (keto cereal), CIYE (smart eyewear and wearable performance tracking, tied to Speedo iQ), East Fork (ceramics/home goods), and Form Nutrition (plant-based protein and supplements). Beyond the curated homepage list, portfolio and exit activity includes Sarelly, Sava, Wesper (home sleep-diagnostics platform), Seat Unique, and PlayerData. The firm's clearest exit to date is ClearlyDerm, a South Florida dermatology practice, which was acquired by Schweiger Dermatology Group in October 2024.

Team

  • Charlie Rubin, Partner — fourth-generation member of the Rubin family (son of Pentland Group deputy chair Andy Rubin); an Investment Professional at Pentland Capital since 2021, quoted publicly as "Investor at Pentland Ventures" on recent deals including Sava.
  • Lucas Giacomelli, Principal — consumer-focused investor covering venture deals across the US, Canada, and UK from Seed through Series C; has spoken publicly about the firm's investment decision process.
  • Katie Martin, Investment Manager — describes herself as "Consumer VC Investor" at Pentland Ventures; University of Bristol background; active in a 2026 VC fundamentals fellowship program.
  • Omar Hattea, Investment Manager — rounds out the four-person investment team visible on the firm's own site.

Decision Process

The team is small and tight-knit (four listed investment professionals), operating as the direct-investment arm of a much larger family holding company. Given the Pentland Group ownership structure, ultimate investment authority likely involves group-level sign-off (the Group board is chaired by Stephen Rubin, with Andy Rubin as deputy chair), though the firm does not publish a formal investment-committee structure.

Founder Preferences

The firm's own language emphasizes being "a tight-knit team dedicated to truly understanding the vision, goals, and challenges of every business we partner with," suggesting a preference for close, hands-on relationships over high-volume portfolio construction. Portfolio composition suggests a preference for consumer brand founders with product-market fit signals (retail placement, community traction) over pure pre-launch bets.

Geographic Focus

Primarily UK (London headquarters) and US consumer brands, with at least one confirmed Latin America investment (Sarelly, Mexico City). No stated exclusions on geography beyond this pattern.

Gaps and Uncertainties

Third-party deal trackers (PitchBook, Dealroom, Caplight) also associate the "Pentland" name with Oxford Quantum Circuits' £260M Series C (June 2026, led by Bullhound Capital) — a deep-tech quantum-computing round that sits well outside the stated health-and-wellness consumer thesis. This could not be confirmed against Pentland Ventures' own site, LinkedIn, or direct company statements, and may instead belong to the related-but-distinct "Pentland Capital" entity under the same Pentland Group umbrella. It has been excluded from this record pending clearer attribution.

04Selected Portfolio
Biotech & Life Sciences
Sava
Consumer Apps & Social
CIYE
E-commerce & Marketplaces
Cadence·Seat Unique·Sarelly
Food & Beverage
Algae Cooking Club·BRAMI·Catalina Crunch·East Fork·Form Nutrition
Gaming
Playerdata
Healthcare & Digital Health
ClearlyDerm·Wesper
Open the full portfolio→
05Recent Updates

Fresh signals from public announcements, essays, and portfolio activity.

See full activity (6) →
Backed Seat Unique's £20M raise, alongside England captain Harry Kane, to accelerate international expansion of the premium ticketing and hospitality platform.
INVESTMENT·seatunique.com
JUN 22, 2026
Led PlayerData's $12M Series A for GPS sports-performance tracking wearables, alongside Darco Ventures and Bolt Ventures.
INVESTMENT·altss.com
MAY 2026
Backed Sava's $19M Series A for its next-generation continuous glucose monitoring biosensor; investor Charlie Rubin commented publicly on the raise.
INVESTMENT·sava.health
JUL 31, 2025
Participated in Sarelly's $3M seed round for the Mexican clean-beauty and fashion-accessories brand.
INVESTMENT·businessoffashion.com
JUL 23, 2025
Portfolio company ClearlyDerm, a South Florida dermatology practice, was acquired by Schweiger Dermatology Group, adding five offices.
EXIT·prnewswire.com
OCT 23, 2024
06Similar Firms
LC
L Catterton
$50M – $750M · Growth
→
RV
Ridgeline Ventures
$1M – $5M · Series A
→
VV
V3 Ventures
$1M – $5M · Pre-Seed · Seed
→
BT
Break Trail Ventures
$500K – $5M · Pre-Seed · Seed
→
S
Science
$500K – $5M · Pre-Seed · Seed
→
Quick Reference
Check Size
$500K – $5M
Stages
Seed · Series A · Series B · Growth
Decision
Investment Committee
Warm Intro
Preferred
Involvement
Advisor
Location
London, UK
Sector Focus
Travel & HospitalityE-Commerce & MarketplacesFood & BeverageHealthcare & Digital Health
Models
Consumer BrandsDirect-To-ConsumerHealth & Wellness
Technology
WearablesBiosensors
See all Travel & Hospitality investors →See all E-commerce & Marketplaces investors →See all Food & Beverage investors →
Visit pentland.vc ↗

See how Pentland Ventures matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Focus Areas
Travel & HospitalityE-Commerce & MarketplacesFood & BeverageHealthcare & Digital Health

See how Pentland Ventures matches your startup

Get a personalized match report in minutes.

Get Your Match Report
Is this your firm? Claim your profile
F4 Intelligence Report · Last Researched September 14, 2026F4 Research Engine